{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cardiac hypertrophy", "Danio rerio", "Developmental toxicity", "Momordica charantia"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31340810", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "07", "Day": "24"}], "Language": ["eng"], "ELocationID": ["184", "10.1186/s12906-019-2599-0"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "19", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Jul", "Day": "24"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos.", "Pagination": {"StartPage": "184", "MedlinePgn": "184"}, "Abstract": {"AbstractText": ["Bitter gourd (Momordica charantia) has attracted the focus of researchers owing to its excellent anti-diabetic action. The beneficial effect of Momordica charantia on heart has been reported by in vitro and in vivo studies. However the developmental toxicity or potential risk of M. charantia on fetus heart development is largely unknown. Hence this study was designed to find out the developmental toxicity of M. charantia using zebrafish (Danio rerio) embryos.", "The crude extracts were prepared from fruit and seeds of M. charantia. The Zebrafish embryos were exposed to serial dilution of each of the crude extract. The biologically active fractions were fractionated by C18 column using high pressure liquid chromatography. Fourier-transform infrared spectroscopy and gas chromatography coupled with mass spectrophotometry was done to identify chemical constituents in fruit and seed extract of M. charantia.", "The seed extract of M. charantia was lethal with LD<sub>50</sub> values of 50\u2009\u03bcg/ml to zebrafish embryos and multiple anomalies were observed in zebrafish embryos at sub-lethal concentration. However, the fruit extract was much safe and exposing the zebrafish embryos even to 200\u2009\u03bcg/ml did not result any lethality. The fruit extract induced severe cardiac hypertrophy in treated embryos. The time window treatment showed that M. charantia perturbed the cardiac myoblast specification process in treated zebrafish embryos. The Fourier-transform infrared spectroscopy analyses revealed diverse chemical group in the active fruit fraction and five new type of compounds were identified in the crude seeds extract of M. charantia by gas chromatography and mass spectrophotometry.", "The teratogenicity of seeds extract and cardiac toxicity by the fruit extract of M. charantia warned that the supplementation made from the fruit and seeds of M. charantia should be used with much care in pregnant diabetic patients to avoid possible damage to developing fetus."]}, "AuthorList": [{"Identifier": ["0000-0001-9891-2443"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioproducts Research Chair, College of Science, Department of Zoology, King Saud University, P.O. Box 2455, Riyadh, 11451, Kingdom of Saudi Arabia. fmuhammad@ksu.edu.sa."}], "LastName": "Khan", "ForeName": "Muhammad Farooq", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioproducts Research Chair, College of Science, Department of Zoology, King Saud University, P.O. Box 2455, Riyadh, 11451, Kingdom of Saudi Arabia."}], "LastName": "Abutaha", "ForeName": "Nael", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Aromatic, and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia."}], "LastName": "Nasr", "ForeName": "Fahd A", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Aromatic, and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia."}], "LastName": "Alqahtani", "ForeName": "Ali S", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Aromatic, and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia."}], "LastName": "Noman", "ForeName": "Omar M", "Initials": "OM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioproducts Research Chair, College of Science, Department of Zoology, King Saud University, P.O. Box 2455, Riyadh, 11451, Kingdom of Saudi Arabia."}], "LastName": "Wadaan", "ForeName": "Mohammad A M", "Initials": "MAM"}], "GrantList": [{"GrantID": "scientific research chairs", "Agency": "Deanship of Scientific Research, King Saud University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemistry", "toxicity"], "DescriptorName": "Fruit"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lethal Dose 50"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry", "toxicity"], "DescriptorName": "Momordica charantia"}, {"QualifierName": ["analysis", "toxicity"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "toxicity"], "DescriptorName": "Seeds"}, {"QualifierName": ["embryology"], "DescriptorName": "Zebrafish"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol. 2004;93(1):123\u2013132.", "ArticleIdList": ["15182917"]}, {"Citation": "Beloin N, Gbeassor M, Akpagana K, Hudson J, de Soussa K, Koumaglo K, Arnason JT. Ethnomedicinal uses of Momordicacharantia (Cucurbitaceae) in Togo and relation to its phytochemistry and biological activity. J Ethnopharmacol. 2005;96(1\u20132):49\u201355.", "ArticleIdList": ["15588650"]}, {"Citation": "Saxena A, Vikram NK. Role of selected Indian plants in management of type 2 diabetes: a review. J Altern Complement Med. 2004;10(2):369\u2013378.", "ArticleIdList": ["15165418"]}, {"Citation": "Soo May L, Sanip Z, Ahmed Shokri A, Abdul Kadir A, Md Lazin MR. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: a single-blinded, randomized controlled trial. Complement Ther Clin Pract. 2018;32:181\u2013186.", "ArticleIdList": ["30057048"]}, {"Citation": "Cortez-Navarrete M, Martinez-Abundis E, Perez-Rubio KG, Gonzalez-Ortiz M, Mendez-Del Villar M. Momordica charantia administration improves insulin secretion in type 2 diabetes mellitus. J Med Food. 2018;21(7):672\u2013677.", "ArticleIdList": ["29431598"]}, {"Citation": "Krawinkel MB, Ludwig C, Swai ME, Yang RY, Chun KP, Habicht SD. Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania. J Ethnopharmacol. 2018;216:1\u20137.", "ArticleIdList": ["29339109"]}, {"Citation": "Inayat UR, Khan RU, Khalil Ur R, Bashir M. Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients. Nutr J. 2015;14:13.", "ArticleIdList": ["PMC4417309", "25623883"]}, {"Citation": "Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health-Syst Ph. 2003;60(4):356\u2013359.", "ArticleIdList": ["12625217"]}, {"Citation": "Chen JC, Liu WQ, Lu L, Qiu MH, Zheng YT, Yang LM, Zhang XM, Zhou L, Li ZR. Kuguacins F-S, cucurbitane triterpenoids from Momordica charantia. Phytochemistry. 2009;70(1):133\u2013140.", "ArticleIdList": ["19041990"]}, {"Citation": "Sonibare MA, Moody JO, Adesanya EO. Use of medicinal plants for the treatment of measles in Nigeria. J Ethnopharmacol. 2009;122(2):268\u2013272.", "ArticleIdList": ["19168120"]}, {"Citation": "Chunthorng-Orn J, Panthong S, Itharat A. Antimicrobial, antioxidant activities and total phenolic content of Thai medicinal plants used to treat HIV patients. J Med Assoc Thai. 2012;95(Suppl 1):S154\u2013S158.", "ArticleIdList": ["23964459"]}, {"Citation": "Poolperm S, Jiraungkoorskul W. An update review on the anthelmintic activity of bitter gourd, Momordica charantia. Pharmacogn Rev. 2017;11(21):31\u201334.", "ArticleIdList": ["PMC5414453", "28503051"]}, {"Citation": "Chao CY, Sung PJ, Wang WH, Kuo YH. Anti-inflammatory effect of Momordica charantia in sepsis mice. Molecules. 2014;19(8):12777\u201312788.", "ArticleIdList": ["PMC6270741", "25153878"]}, {"Citation": "Jha DK, Koneri R, Samaddar S. Medicinal use of an ancient herb Momordica Cymbalaria: a review. Int J Pharm Sci Res. 2018;9(2):432\u2013441."}, {"Citation": "Hussan F, Yahaya MF, Teoh SL, Das S. Herbs for effective treatment of diabetes mellitus wounds: medicinal chemistry and future therapeutic options. Mini-Rev Med Chem. 2018;18(8):697\u2013710.", "ArticleIdList": ["28971772"]}, {"Citation": "Alippilakkotte S, Kumar S, Sreejith L. Fabrication of PLA/ag nanofibers by green synthesis method using Momordica charantia fruit extract for wound dressing applications. Colloid Surface A. 2017;529:771\u2013782."}, {"Citation": "Abu Bakar FI, Abu Bakar MF, Rahmat A, Abdullah N, Sabran SF, Endrini S. Anti-gout potential of Malaysian medicinal plants. Front Pharmacol. 2018;9:261.", "ArticleIdList": ["PMC5876239", "29628890"]}, {"Citation": "Jia S, Shen MY, Zhang F, Xie JH. Recent advances in Momordica charantia: functional components and biological activities. Int J Mol Sci. 2017;18(12). Int J Mol Sci. 2017;18:2555. 10.3390/ijms1812255.", "ArticleIdList": ["PMC5751158", "29182587"]}, {"Citation": "Wang SZ, Li ZL, Yang GL, Ho CT, Li SM. Momordica charantia: a popular health-promoting vegetable with multifunctionality. Food Funct. 2017;8(5):1749\u20131762.", "ArticleIdList": ["28474032"]}, {"Citation": "Rashid MMO, Ferdous J, Banik S, Islam MR, Uddin AHMM, Robel FN. Anthelmintic activity of silver-extract nanoparticles synthesized from the combination of silver nanoparticles and M. charantia fruit extract. BMC Complem Altern M. 2016;16:242.", "ArticleIdList": ["PMC4960788", "27457362"]}, {"Citation": "Upadhyay A, Agrahari P, Singh DK. A review on salient pharmacological features of Momordica charantia. Int J Pharmacol. 2015;11(5):405\u2013413."}, {"Citation": "Licastro F, Franceschi C, Barbieri L, Stirpe F. Toxicity of Momordica charantia lectin and inhibitor for human normal and leukaemic lymphocytes. Virchows Arch B Cell Pathol Incl Mol Pathol. 1980;33(3):257\u2013265.", "ArticleIdList": ["6110273"]}, {"Citation": "da Silva TB, Costa CO, Galvao AF, Bomfim LM, Rodrigues AC, Mota MC, Dantas AA, Dos Santos TR, Soares MB, Bezerra DP. Cytotoxic potential of selected medicinal plants in Northeast Brazil. BMC Complement Altern Med. 2016;16:199.", "ArticleIdList": ["PMC4938922", "27391476"]}, {"Citation": "Bai LY, Chiu CF, Chu PC, Lin WY, Chiu SJ, Weng JR. A triterpenoid from wild bitter gourd inhibits breast cancer cells. Sci Rep. 2016;6:22419.", "ArticleIdList": ["PMC4772478", "26926586"]}, {"Citation": "Pitchakarn P, Suzuki S, Ogawa K, Pompimon W, Takahashi S, Asamoto M, Limtrakul P, Shirai T. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3. Food Chem Toxicol. 2012;50(3\u20134):840\u2013847.", "ArticleIdList": ["22266361"]}, {"Citation": "Ru P, Steele R, Nerurkar PV, Phillips N, Ray RB. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model. Cancer Prev Res (Phila) 2011;4(12):2122\u20132130.", "ArticleIdList": ["PMC3232292", "21911444"]}, {"Citation": "Pitchakarn P, Suzuki S, Ogawa K, Pompimon W, Takahashi S, Asamoto M, Limtrakul P, Shirai T. Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf. Cancer Lett. 2011;306(2):142\u2013150.", "ArticleIdList": ["21429659"]}, {"Citation": "Pitchakarn P, Ogawa K, Suzuki S, Takahashi S, Asamoto M, Chewonarin T, Limtrakul P, Shirai T. Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo. Cancer Sci. 2010;101(10):2234\u20132240.", "ArticleIdList": ["20731662"]}, {"Citation": "Singh J, Cumming E, Manoharan G, Kalasz H, Adeghate E. Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions. Open Med Chem J. 2011;5(Suppl 2):70\u201377.", "ArticleIdList": ["PMC3174519", "21966327"]}, {"Citation": "Raman A, Lau C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae) Phytomedicine. 1996;2(4):349\u2013362.", "ArticleIdList": ["23194773"]}, {"Citation": "Wang L, Clardy A, Hui DF, Gao AW, Wu Y. Antioxidant and antidiabetic properties of Chinese and Indian bitter melons (Momordica charantia L.) Food Biosci. 2019;29:73\u201380."}, {"Citation": "Njume C, Donkor O, McAinch AJ. Predisposing factors of type 2 diabetes mellitus and the potential protective role of native plants with functional properties. J Funct Foods. 2019;53:115\u2013124."}, {"Citation": "Wan-Nadilah WA, Khozirah S, Khatib A, Hamid AA, Hamid M. Evaluation of the alpha-glucosidase inhibitory and free radical scavenging activities of selected traditional medicine plant species used in treating diabetes. Int Food Res J. 2019;26(1):75\u201385."}, {"Citation": "Maneenin C, Burawat J, Maneenin N, Nualkaew S, Arun S, Sampannang A, Iamsaard S. Antioxidant capacity of Momordica charantia extract and its protective effect on testicular damage in Valproic acid-induced rats. Int J Morphol. 2018;36(2):447\u2013453."}, {"Citation": "Sandikapura MJ, Nyamathulla S, Noordin MI. Comparative antioxidant and antidiabetic effects of Syzygium polyanthum leaf and Momordica charantia fruit extracts. Pak J Pharm Sci. 2018;31(2):623\u2013635.", "ArticleIdList": ["29625934"]}, {"Citation": "Torkamani AE, Syahariza ZA, Norziah MH, Wan AKM, Juliano P. Encapsulation of polyphenolic antioxidants obtained from Momordica charantia fruit within zein/gelatin shell core fibers via coaxial electrospinning. Food Biosci. 2018;21:60\u201371."}, {"Citation": "Tripathi UN, Chandra D. The plant extracts of Momordica charantia and Trigonella foenum graecum have antioxidant and anti-hyperglycemic properties for cardiac tissue during diabetes mellitus. Oxidative Med Cell Longev. 2009;2(5):290\u2013296.", "ArticleIdList": ["PMC2835917", "20716916"]}, {"Citation": "Raish M. Momordica charantia polysaccharides ameliorate oxidative stress, hyperlipidemia, inflammation, and apoptosis during myocardial infarction by inhibiting the NF-kappaB signaling pathway. Int J Biol Macromol. 2017;97:544\u2013551.", "ArticleIdList": ["28109806"]}, {"Citation": "Abas R, Othman F, Thent ZC. Protective effect of Momordica charantia fruit extract on hyperglycaemia-induced cardiac fibrosis. Oxidative Med Cell Longev. 2014;2014:429060.", "ArticleIdList": ["PMC4211142", "25371774"]}, {"Citation": "Barrow P. Revision of the ICH guideline on detection of toxicity to reproduction for medicinal products: SWOT analysis. Reprod Toxicol. 2016;64:57\u201363.", "ArticleIdList": ["27046733"]}, {"Citation": "Bass R, Ulbrich B, Hildebrandt AG, Weissinger J, Doi O, Baeder C, Fumero S, Harada Y, Lehmann H, Manson J, et al. Draft guideline on detection of toxicity to reproduction for medicinal products. Adverse Drug React T. 1991;10(3):127\u2013141.", "ArticleIdList": ["1747440"]}, {"Citation": "Pina B, Navarro L, Barata C, Raldua D, Martinez R, Casado M. Omics in zebrafish Teratogenesis. Methods Mol Biol. 2018;1797:421\u2013441.", "ArticleIdList": ["29896707"]}, {"Citation": "Nishimura Y, Inoue A, Sasagawa S, Koiwa J, Kawaguchi K, Kawase R, Maruyama T, Kim S, Tanaka T. Using zebrafish in systems toxicology for developmental toxicity testing. Congenit Anom. 2016;56(1):18\u201327.", "ArticleIdList": ["26537640"]}, {"Citation": "Kanungo J, Cuevas E, Ali SF, Paule MG. Zebrafish model in drug safety assessment. Curr Pharm Des. 2014;20(34):5416\u20135429.", "ArticleIdList": ["24502596"]}, {"Citation": "Gibert Y, Trengove MC, Ward AC. Zebrafish as a genetic model in pre-clinical drug testing and screening. Curr Med Chem. 2013;20(19):2458\u20132466.", "ArticleIdList": ["23521675"]}, {"Citation": "Teraoka H, Dong W, Hiraga T. Zebrafish as a novel experimental model for developmental toxicology. Congenit Anom. 2003;43(2):123\u2013132.", "ArticleIdList": ["12893971"]}, {"Citation": "Nishimura Y, Murakami S, Ashikawa Y, Sasagawa S, Umemoto N, Shimada Y, Tanaka T. Zebrafish as a systems toxicology model for developmental neurotoxicity testing. Congenit Anom. 2015;55(1):1\u201316.", "ArticleIdList": ["25109898"]}, {"Citation": "Ota S, Kawahara A. Zebrafish: a model vertebrate suitable for the analysis of human genetic disorders. Congenit Anom. 2014;54(1):8\u201311.", "ArticleIdList": ["24279334"]}, {"Citation": "Arenzana FJ, Carvan MJ, 3rd, Aijon J, Sanchez-Gonzalez R, Arevalo R, Porteros A. Teratogenic effects of ethanol exposure on zebrafish visual system development. Neurotoxicol Teratol. 2006;28(3):342\u2013348.", "ArticleIdList": ["16574376"]}, {"Citation": "Hidayathulla S, Shahat AA, Ahamad SR, Al Moqbil AAN, Alsaid MS, Divakar DD. GC/MS analysis and characterization of 2-Hexadecen-1-ol and beta sitosterol from Schimpera arabica extract for its bioactive potential as antioxidant and antimicrobial. J Appl Microbiol. 2018;124(5):1082\u20131091.", "ArticleIdList": ["29356238"]}, {"Citation": "Shanker K, Naradala J, Mohan GK, Kumar GS, Pravallika PL. A sub-acute oral toxicity analysis and comparative in vivo anti-diabetic activity of zinc oxide, cerium oxide, silver nanoparticles, and Momordica charantia in streptozotocin-induced diabetic Wistar rats. RSC Adv. 2017;7(59):37158\u201337167."}, {"Citation": "Deshmukh NS. Safety assessment of McB-E60 (extract of a Momordica sp.): subchronic toxicity study in rats. Toxicol Rep. 2016;3:481\u2013489.", "ArticleIdList": ["PMC5615932", "28959571"]}, {"Citation": "Xu X, Shan B, Liao CH, Xie JH, Wen PW, Shi JY. Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice. Int J Biol Macromol. 2015;81:538\u2013543.", "ArticleIdList": ["26318666"]}, {"Citation": "Karan SK, Mondal A, Mishra SK, Pal D, Rout KK. Antidiabetic effect of Streblus asper in streptozotocin-induced diabetic rats. Pharm Biol. 2013;51(3):369\u2013375.", "ArticleIdList": ["23406357"]}, {"Citation": "Zahra K, Malik MA, Mughal MS, Arshad M, Sohail MI. Hepatoprotective role of extracts of Momordica Charantia L. in acetaminophen-induced toxicity in rabbits. J Anim Plant Sci. 2012;22(2):273\u2013277."}, {"Citation": "Verissimo LF, Bacchi AD, Zaminelli T, de Paula GHO, Moreira EG. Herbs of interest to the Brazilian Federal Government: female reproductive and developmental toxicity studies. Rev Bras Farmacogn. 2011;21(6):1163\u20131171."}, {"Citation": "Uche-Nwachi EO, McEwen C. Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats. Afr J Tradit Complement Altern Med. 2009;7(1):24\u201333.", "ArticleIdList": ["PMC3005383", "21304609"]}, {"Citation": "Sheffield JS, Siegel D, Mirochnick M, Heine RP, Nguyen C, Bergman KL, Savic RM, Long J, Dooley KE, Nesin M. Designing drug trials: considerations for pregnant women. Clin Infect Dis. 2014;59(Suppl 7):S437\u2013S444.", "ArticleIdList": ["PMC4303056", "25425722"]}, {"Citation": "Sekar DS, Sivagnanam K, Subramanian S. Antidiabetic activity of Momordica charantia seeds on streptozotocin induced diabetic rats. Die Pharmazie. 2005;60(5):383\u2013387.", "ArticleIdList": ["15918591"]}, {"Citation": "Ahmad Z, Zamhuri KF, Yaacob A, Siong CH, Selvarajah M, Ismail A, Nazrul Hakim M. In vitro anti-diabetic activities and chemical analysis of polypeptide-k and oil isolated from seeds of Momordica charantia (bitter gourd) Molecules. 2012;17(8):9631\u20139640.", "ArticleIdList": ["PMC6268611", "22885359"]}, {"Citation": "Teixido E, Piqu\u00e9 E, Boix N, Llobet J, Gomez J. Zebrafish as a model for developmental toxicity assessment. 2015. pp. 65\u201383."}, {"Citation": "Sipes NS, Padilla S, Knudsen TB. Zebrafish-as an integrative model for twenty-first century toxicity testing. Birth Defects Res C. 2011;93(3):256\u2013267.", "ArticleIdList": ["21932434"]}, {"Citation": "Behl M, Hsieh JH, Shafer TJ, Mundy WR, Rice JR, Boyd WA, Freedman JH, Hunter ES, Jarema KA, Padilla S, et al. Use of alternative assays to identify and prioritize organophosphorus flame retardants for potential developmental and neurotoxicity. Neurotoxicol Teratol. 2015;52:181\u2013193.", "ArticleIdList": ["26386178"]}, {"Citation": "Zang LQ, Shimada Y, Nishimura N. Development of a novel zebrafish model for type 2 diabetes mellitus. Sci Rep. 2017;7:1461.", "ArticleIdList": ["PMC5431185", "28469250"]}, {"Citation": "Pereira J, Camara JS. Effectiveness of different solid-phase microextraction fibres for differentiation of selected Madeira island fruits based on their volatile metabolite profile--identification of novel compounds. Talanta. 2011;83(3):899\u2013906.", "ArticleIdList": ["21147335"]}, {"Citation": "Sena S, Rasmussen IR, Wende AR, McQueen AP, Theobald HA, Wilde N, Pereira RO, Litwin SE, Berger JP, Abel ED. Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling. Endocrinology. 2007;148(12):6047\u20136053.", "ArticleIdList": ["17823261"]}, {"Citation": "Bakkers J. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res. 2011;91(2):279\u2013288.", "ArticleIdList": ["PMC3125074", "21602174"]}, {"Citation": "Stainier DY, Lee RK, Fishman MC. Cardiovascular development in the zebrafish. I. Myocardial fate map and heart tube formation. Development. 1993;119(1):31\u201340.", "ArticleIdList": ["8275863"]}, {"Citation": "Dahme T, Katus HA, Rottbauer W. Fishing for the genetic basis of cardiovascular disease. Dis Model Mech. 2009;2(1\u20132):18\u201322.", "ArticleIdList": ["PMC2615162", "19132116"]}, {"Citation": "Erden I, Ordu S, Erden EC, Caglar SO. A case of atrial fibrillation due to Momordica charantia (bitter melon) Ann Saudi Med. 2010;30(1):86\u201387.", "ArticleIdList": ["PMC2850191", "20103967"]}, {"Citation": "Westerfield M. Zebrafish book: a guide for the laboratory use of zebrafish (Danio rerio) 5. Eugene: University of Oregon Press; 2007."}, {"Citation": "Strahle U, Scholz S, Geisler R, Greiner P, Hollert H, Rastegar S, Schumacher A, Selderslaghs I, Weiss C, Witters H, et al. Zebrafish embryos as an alternative to animal experiments-a commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod Toxicol. 2012;33(2):128\u2013132.", "ArticleIdList": ["21726626"]}, {"Citation": "Bartlett DH, Silk SB. Office of Laboratory Animal Welfare Comments. Zebrafish. 2016;13(6):563\u2013564.", "ArticleIdList": ["PMC5124735", "27779465"]}]}], "History": [{"Year": "2019", "Month": "5", "Day": "22"}, {"Year": "2019", "Month": "7", "Day": "16"}, {"Year": "2019", "Month": "7", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["31340810", "PMC6657154", "10.1186/s12906-019-2599-0", "10.1186/s12906-019-2599-0"]}}]}